J. Honorato

696 total citations
29 papers, 532 citations indexed

About

J. Honorato is a scholar working on Pharmacology, Epidemiology and Surgery. According to data from OpenAlex, J. Honorato has authored 29 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 6 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in J. Honorato's work include Antibiotics Pharmacokinetics and Efficacy (7 papers), Analytical Methods in Pharmaceuticals (4 papers) and Pneumonia and Respiratory Infections (4 papers). J. Honorato is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (7 papers), Analytical Methods in Pharmaceuticals (4 papers) and Pneumonia and Respiratory Infections (4 papers). J. Honorato collaborates with scholars based in Spain, Mexico and Brazil. J. Honorato's co-authors include E. García-Quetglás, M. A. Campanero, Antonio Álvarez, Javier de Gracia, Fernando Baquero, Silvia Gärtner, Antonio Oliver, Antonio Salcedo, Rafael Cantón and N. Cobos and has published in prestigious journals such as Clinical Microbiology and Infection, Journal of Pharmaceutical and Biomedical Analysis and International Journal of Oral and Maxillofacial Surgery.

In The Last Decade

J. Honorato

24 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Honorato Spain 11 156 108 87 85 80 29 532
Steven Pauwels Belgium 14 69 0.4× 35 0.3× 130 1.5× 162 1.9× 90 1.1× 33 801
Haresh Mirchandani United States 10 103 0.7× 16 0.1× 45 0.5× 18 0.2× 16 0.2× 14 550
Gerard F. Cooney United States 14 64 0.4× 18 0.2× 33 0.4× 156 1.8× 67 0.8× 33 689
David McDougall Australia 11 62 0.4× 15 0.1× 56 0.6× 63 0.7× 78 1.0× 25 387
Hjalmar Lagast Belgium 17 37 0.2× 16 0.1× 140 1.6× 242 2.8× 177 2.2× 48 1.2k
W.-R Külpmann Germany 11 46 0.3× 39 0.4× 61 0.7× 14 0.2× 45 0.6× 38 487
D. N. Crozier Canada 11 392 2.5× 10 0.1× 42 0.5× 44 0.5× 38 0.5× 18 558
Marcelo Rodrigues Bacci Brazil 12 48 0.3× 6 0.1× 96 1.1× 55 0.6× 123 1.5× 47 571
Stéphanie Leroux France 14 53 0.3× 8 0.1× 23 0.3× 302 3.6× 179 2.2× 43 585

Countries citing papers authored by J. Honorato

Since Specialization
Citations

This map shows the geographic impact of J. Honorato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Honorato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Honorato more than expected).

Fields of papers citing papers by J. Honorato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Honorato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Honorato. The network helps show where J. Honorato may publish in the future.

Co-authorship network of co-authors of J. Honorato

This figure shows the co-authorship network connecting the top 25 collaborators of J. Honorato. A scholar is included among the top collaborators of J. Honorato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Honorato. J. Honorato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Honorato, J., Jesús Repáraz, & Rosario Ortolá. (2017). Fosfomicina en bronconeumopatías agudas. Revista de medicina de la Universidad de Navarra. 85–94.
2.
Honorato, J., et al.. (2017). Estudio clínico-farmacológico lineal del Butibufen en afecciones reumáticas. Revista de medicina de la Universidad de Navarra. 165–178.
3.
Honorato, J., Marise Souto Rebelo, Fernando Luiz Dias, et al.. (2015). Gender differences in prognostic factors for oral cancer. International Journal of Oral and Maxillofacial Surgery. 44(10). 1205–1211. 25 indexed citations
4.
Barrios, Vivencio, Carlos Escobar, Mariano de la Figuera, et al.. (2008). High doses of lercanidipine are better tolerated than other dihydropyridines in hypertensive patients with metabolic syndrome: results from the TOLERANCE study. International Journal of Clinical Practice. 62(5). 723–728. 15 indexed citations
5.
Sádaba, Belén, José Ramón Azanza Perea, M. A. Campanero, et al.. (2007). Pharmacokinetic/pharmacodynamic serum and urine profile of cefditoren following single-dose and multiple twice- and thrice-daily regimens in healthy volunteers: a phase I study.. PubMed. 20(1). 51–60. 19 indexed citations
6.
Arroyo, Roberto Alcázar, J. Honorato, Nicolás Roberto Robles, et al.. (2006). [Practical management of oral antidiabetics in patients with renal disease].. PubMed. 26(5). 538–58. 2 indexed citations
7.
Cantón, Rafael, N. Cobos, Javier de Gracia, et al.. (2005). Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients. Clinical Microbiology and Infection. 11(9). 690–703. 119 indexed citations
8.
Cantón, Rafael, N. Cobos, Javier de Gracia, et al.. (2005). Tratamiento antimicrobiano frente a la colonización pulmonar por Pseudomonas aeruginosa en el paciente con fibrosis quística. Archivos de Bronconeumología. 41. 1–25. 69 indexed citations
9.
M, Díaz Curiel, Javier Garcia, José Luís Carrasco, et al.. (2001). Prevalencia de osteoporosis determinada por densitometría en la población femenina española. Medicina Clínica. 116(3). 86–88. 128 indexed citations
10.
González‐Peñas, Elena, et al.. (2001). A sensitive method for the determination of gemfibrozil in human plasma samples by RP-LC. Journal of Pharmaceutical and Biomedical Analysis. 26(1). 7–14. 20 indexed citations
11.
Baquero, F., Juan Campos, José Castillo, et al.. (2000). Recommendations from MENSURA for selection of antimicrobial agents for susceptibility testing and criteria for the interpretation of antibiograms [Recomendaciones del grupo MENSURA para la seleccion de antimicrobianos en el estudio de la sensibilidad y criterios para la interpretacion del antibiograma]. Revista española de quimioterapia. Suplemento. 13(1). 73–86. 19 indexed citations
12.
Campanero, M. A., et al.. (1999). Rapid liquid chromatographic assay for the determination of acetaminophen in plasma after propacetamol administration: application to pharmacokinetic studies. Journal of Pharmaceutical and Biomedical Analysis. 20(1-2). 327–334. 34 indexed citations
14.
Campanero, M. A., et al.. (1998). Determination of cisapride in human plasma by high-performance liquid chromatography. Chromatographia. 47(9-10). 537–541. 12 indexed citations
15.
Honorato, J., et al.. (1995). Cimetidine does not alter sparfloxacin pharmacokinetics.. PubMed. 33(11). 585–7. 4 indexed citations
16.
Honorato, J. & Marina P. Catalán. (1990). [Buspirone: a new non-benzodiazepine anxiolytic drug].. PubMed. 186(6). 286–91. 2 indexed citations
17.
Richter, J, et al.. (1984). [67gallium. Diagnostic possibilities and usefulness as a tracer].. PubMed. 28(3). 17–22. 1 indexed citations
18.
Honorato, J., et al.. (1984). [Double-blind parallel clinical trial with tenoxicam in comparison with indomethacin in the treatment of rheumatoid arthritis].. PubMed. 28(3). 49–53. 1 indexed citations
19.
Honorato, J., et al.. (1977). Fosfomycin in Acute Bronchopneumopathies. Chemotherapy. 23(1). 331–336. 4 indexed citations
20.
Honorato, J., et al.. (1976). The Use of Gemfibrozil in the Treatment of Primary Hyperlipoproteinæmia. Preliminary Report. Proceedings of the Royal Society of Medicine. 69(2_suppl). 78–79. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026